{"database":"ENA","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Fastqsanger.gz":["ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/017/SRR12247917/SRR12247917_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/018/SRR12247918/SRR12247918_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/019/SRR12247919/SRR12247919_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/016/SRR12247916/SRR12247916_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/021/SRR12247921/SRR12247921_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/020/SRR12247920/SRR12247920_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/017/SRR12247917/SRR12247917_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/016/SRR12247916/SRR12247916_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/018/SRR12247918/SRR12247918_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/021/SRR12247921/SRR12247921_1.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/020/SRR12247920/SRR12247920_2.fastq.gz","ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR122/019/SRR12247919/SRR12247919_1.fastq.gz"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"center_name":["Hepatology, The Third Hospital of Hebei Medical University"],"full_dataset_link":["https://www.ebi.ac.uk/ena/browser/view/PRJNA646928"],"scientific_name":["Homo sapiens"],"tag":["xref:PubMed:33015132"],"long_description":["Hepatitis C virus (HCV) infection is an important etiology of chronic liver disease. Multiple possible molecular mechanisms were involved in the progression of liver fibrosis in chronically HCV-infected patients. Therefore, the further revealing novel genes for regulating liver fibrosis might provide evidence for gene diagnosis and molecular-targeted therapy. In this study, we examined the differentially expressed mRNA in plasma samples from the healthy control and patients with HCV-related liver fibrosis, in order to explore the potential predicted and therapeutic target for the development of HCV-related liver fibrosis. Overall design: Plasma samples from HCV patients with moderate to severe liver fibrosis (F3-4) and healthy control subjects (each group included 3 cases) were used for whole transcript digital gene expression (DGE) profiling sequencing."],"repository":["ENA"],"description_synonyms":["human hepatitis C virus HCV, human hepatitis C virus, hepatitis C virus HCV, Gene Expressions, Patient, determination, Liver fibrosis., Clients, chemical analysis, post-transfusion hepatitis non A non B virus, Gene, Expression, assay, HCV, Expressions, Client, Hepatitis C"],"name_synonyms":["human hepatitis C virus HCV, human hepatitis C virus, hepatitis C virus HCV, Gene Expressions, Patient, determination, Liver fibrosis., Clients, chemical analysis, post-transfusion hepatitis non A non B virus, Gene, Expression, assay, HCV, Expressions, Client, Hepatitis C"],"additional_accession":[]},"is_claimable":false,"name":"Digital Gene Expression profiles analysis of patients with HCV-related hepatic fibrosis","description":"Digital Gene Expression profiles analysis of patients with HCV-related hepatic fibrosis","dates":{"last_updated":"2025-09-24","first_public":"2020-09-12"},"accession":"PRJNA646928","cross_references":{"GEO":["GSE154055"],"taxon":["9606"],"PubMed":["33015132"]}}